Supplemental Figure 1 A GENE chr location (hg18) SNP sample ID TLR2

Slides:



Advertisements
Similar presentations
ATG GAG GAA GAA GAT GAA GAG ATC TTA TCG TCT TCC GAT TGC GAC GAT TCC AGC GAT AGT TAC AAG GAT GAT TCT CAA GAT TCT GAA GGA GAA AAC GAT AAC CCT GAG TGC GAA.
Advertisements

Supplementary Fig.1: oligonucleotide primer sequences.
Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway Supplementary Data Files in this Data Supplement: Supplementary.
Supplementary data d a c d ab b Figure S1. Quantification of the Western blot data in figure 4C. The area density of each band was measured with a UVP.
Sh-luc shSCP1-1 * IB: c-Myc IB: Tubulin shSCP1-2 IB: p-Ser KD 70KD 60KD 70KD (abnova) sh-luc shSCP1-1 * IB: c-Myc IB: Tubulin shSCP1-2.
TRS1 rpS6 28S 18S B A Oligo(dT) Input +MN TRS1 +m 7 GTP His PABP Figure S1. pTRS1 associates with the mRNA body independent of the.
B Supplementary Fig S1. (A) ZR75- and MCF7-PELP1 knockdown cells were generated as described in methods section. Pooled colonies were analyzed for PELP1.
Leimgruber et al. Supplementary Figure 1 Supplementary Figure 1. The S’-Y’ and S-Y modules of the HLA-DRA gene exhibit lower levels of H4Ac, reduced nucleosome.
AntimiR-30b Inhibits TNF-α Mediated Apoptosis and Attenuated Cartilage Degradation through Enhancing Autophagy Cell Physiol Biochem 2016;40:
Finding the potential miRNA-binding sites of the selected SNPs
Figure 1. Enhancement of ERα activity by Constitutively Active MEKK1 in Endometrial Cancer Cells A, Ishikawa cells were transfected with 0.5 μg EREe1bCAT.
Volume 141, Issue 4, Pages e5 (October 2011)
Caspase‐2 activation is a prerequisite for TRAIL‐mediated apoptosis.
Phosphorylation of serine 73 targets SREBP-1c for ubiquitination and proteasomal degradation Phosphorylation of serine 73 targets SREBP-1c for ubiquitination.
Takehiko Dohi, Fang Xia, Dario C. Altieri  Molecular Cell 
Calcium regulates ERK nuclear association, but not its activation.
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways by Gilles Despouy, Marjorie Joiner, Emilie Le Toriellec,
Volume 126, Issue 1, Pages (January 2004)
Volume 81, Issue 1, Pages (January 2012)
FAM49B controls T cell activation by regulating cytoskeleton remodeling. FAM49B controls T cell activation by regulating cytoskeleton remodeling. (A) J.FAM49B.
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
REV-ERBα agonists reduce protein O-GlcNAcylation.
Volume 141, Issue 4, Pages e5 (October 2011)
Figure 5 In vitro characterization of the Y290F and T269M GNRHR mutations. A: Competitive binding curves for the Y290F and T269M GNRHR mutants compared.
Supplemental Figure S1 a b
Vascular endothelial growth factor stimulates protein kinase CβII expression in chronic lymphocytic leukemia cells by Simon T. Abrams, Benjamin R. B. Brown,
Volume 126, Issue 1, Pages (January 2004)
MD-2s fails to mediate LPS-dependent NF-κB activation and IL-8 secretion. MD-2s fails to mediate LPS-dependent NF-κB activation and IL-8 secretion. A,
Supplement Figure 3 SYF cells
A B CDK2 CDK2 inhibition P Activated KRAS P CP110 CP110
Multiple PKCδ Tyrosine Residues Are Required for PKCδ-Dependent Activation of Involucrin Expression—a Key Role of PKCδ-Y311  Ling Zhu, Chaya Brodie, Sivaprakasam.
Volume 2, Issue 4, Pages (April 2008)
Volume 11, Issue 12, Pages (June 2015)
MiTF Regulates Cellular Response to Reactive Oxygen Species through Transcriptional Regulation of APE-1/Ref-1  Feng Liu, Yan Fu, Frank L. Meyskens  Journal.
Supplemental Figure 3 A B C T-DNA 1 2 RGLG1 2329bp 3 T-DNA 1 2 RGLG2
SUMO Promotes HDAC-Mediated Transcriptional Repression
Dandan Wang et al. BTS 2018;3: miR-24 Regulates OGT and ATG4A to Play Cardioprotective Effects Sequence alignment of miR-24 targeting sites on OGT.
MED12 interacts with TDRD3 in a CARM1-dependent fashion.
Transcriptional Regulation of ATP2C1 Gene by Sp1 and YY1 and Reduced Function of its Promoter in Hailey–Hailey Disease Keratinocytes  Hiroshi Kawada,
BRCA1 PARsylation is required for normal HRR tuning.
Volume 13, Issue 3, Pages (March 2006)
Volume 16, Issue 24, Pages (December 2006)
Cowden Syndrome–Affected Patients with PTEN Promoter Mutations Demonstrate Abnormal Protein Translation  Rosemary E. Teresi, Kevin M. Zbuk, Marcus G.
Membrane type-1 matrix metalloproteinase is induced following cyclic compression of in vitro grown bovine chondrocytes  J.N.A. De Croos, Ph.D., B. Jang,
c-Src Activates Endonuclease-Mediated mRNA Decay
Volume 18, Issue 6, Pages (December 2015)
Volume 126, Issue 4, Pages (April 2004)
Volume 14, Issue 3, Pages (March 2008)
Nef Triggers a Transcriptional Program in T Cells Imitating Single-Signal T Cell Activation and Inducing HIV Virulence Mediators  Alison Simmons, Varuna.
A B Supplementary Figure S1 PC3 cells Vehicle 3β-Adiol
Supplemental Figure 4 A no agonist MALP2 PAM3CSK4 GFP WT F217S
Cas9/gRNA-mediated gene deficiency in DF-1 cells.
Effect of expression of constitutively active CAMKK2 on AMPK activation and the cell cycle in G361 cells. Effect of expression of constitutively active.
Figure S3. Zhang et al. A B Myc-SIRT1 - + sir2a+/+ sir2a-/-
Changes in mutation rate or protein abundance are not observed in HATs when comparing rho+ to rho0 cells. Changes in mutation rate or protein abundance.
Human embryonic kidney (HEK293T) cells expressing mutated glucose transporter 1-flag gene (MUT-GLUT1-flag) uptake less glucose than their WT-GLUT1-flag.
Figure 4 DNM1 mutations affect protein levels and self-dimerization (A) HeLa cells were transfected with green fluorescent protein (GFP)-tagged mutant.
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
Arginine-to-lysine mutations conferring TRIM22 restriction and lysine-to-arginine mutations causing loss of TRIM22 restriction. Arginine-to-lysine mutations.
Volume 72, Issue 2, Pages (July 2007)
Effect of ERα Ub-binding ability on E2-induced receptor transcriptional activity. Effect of ERα Ub-binding ability on E2-induced receptor transcriptional.
Figure 2. p62−/−MEF cells enhance the activation of NF-κB induced by TLR4. (A) Wild-type (WT) p62+/+MEF and p62−/−MEF cells were transfected with pBIIx-luc.
Regulation of KSHV Lytic Switch Protein Expression by a Virus-Encoded MicroRNA: An Evolutionary Adaptation that Fine-Tunes Lytic Reactivation  Priya Bellare,
Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner  Juan Lama, Aram Mangasarian,
Ectopic expression of CA RSK1 mutant protects melanoma cells from PD98059-mediated apoptosis. Ectopic expression of CA RSK1 mutant protects melanoma cells.
Fig. 4 Effects of hematopoietic restoration of TLR9 on adipose tissue inflammation and insulin resistance. Effects of hematopoietic restoration of TLR9.
Inactivation of human TRAC and CD52 genes by TALENs
Volume 28, Issue 8, Pages e4 (August 2019)
AS1411 alters subcellular distribution of PRMT5 in a time-dependent, dose-dependent, and nucleolin-dependent manner. AS1411 alters subcellular distribution.
Effect of dexamethasone on PCDGF/GP88 mRNA and protein expressions and effect of PCDGF/GP88 on dexamethasone-induced cell death. Effect of dexamethasone.
Presentation transcript:

Supplemental Figure 1 A GENE chr location (hg18) SNP sample ID TLR2 chr4 154845515 CCC-CTC WBM40 154845415 AGC-CGC WBM51 154844159 TTT-TCT WBM57 TLR4 chr9 119515069 TGC-TAC WBM69 B C D #55 E no agonist PAM2CSK4 GFP WT F217S GFP WT F217S p-p38 b-actin Figure S1. Mutational analysis of TLRs in MDS. (a) Identification of three rare SNPs of TLR1 and one rare SNP of TLR4 by captured deep sequencing in MDS BM-MNCs. (b) The presence of TLR2-F217S in both BM-MNC and BM-CD3+ cells of one case of MDS. (c) Lack of TLR2-F217S in BM-MNC or BM-CD3+ cells of another case of MDS. (d) Luciferase analysis of activation of AP1 by WT and F217S TLR2 in transfected 293T cells. Cells were exposed to either no agonist or to PAM2CSK4. (e) Western blot characterization of p38 phosphorylation in 293T cells transfected with either WT or F217S TLR2 and treated with no agonist, MALP2 or PAM2CSK4. Top, Western blot analysis of p-p38; Bottom, Quantification of p-p38 band densities.